Co‐regulation of B‐Myb expression by E2F1 and EGF receptor
暂无分享,去创建一个
Yusuke Nakajima | Chi-Ping Day | M. Hung | H. Lo | N. Hanada | Yong Pan | Y. Nakajima | Mien-Chie Hung | Chi-Ping Day | Hui-Wen Lo | Yong Pan | Norihisa Hanada
[1] T. Grunt,et al. c-erbB-3 , 2002, The Journal of cell biology.
[2] P. Subramaniam,et al. Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-gamma receptor complex following activation by IFN-gamma. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[3] B. Calabretta,et al. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[4] K. Makino,et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor , 2001, Nature Cell Biology.
[5] A. Wells,et al. Signalling shortcuts: cell-surface receptors in the nucleus? , 2002, Nature Reviews Molecular Cell Biology.
[6] P. Subramaniam,et al. Differential Nuclear Localization of the IFNGR-1 and IFNGR-2 Subunits of the IFN-γ Receptor Complex Following Activation by IFN-γ , 2000 .
[7] K. Klempnauer,et al. Differential splicing of the mouse B-myb gene. , 1995, Oncogene.
[8] M. Barker,et al. Localization of epidermal growth factor receptor in hepatocyte nuclei , 1991, Hepatology.
[9] E. Lam,et al. An E2F‐binding site mediates cell‐cycle regulated repression of mouse B‐myb transcription. , 1993, The EMBO journal.
[10] M. Hung,et al. Selective Activation of Ceruloplasmin Promoter in Ovarian Tumors , 2004, Cancer Research.
[11] F. C. Lucibello,et al. Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element. , 1996, Nucleic acids research.
[12] M. Hung,et al. Mitosis-specific Negative Regulation of Epidermal Growth Factor Receptor, Triggered by a Decrease in Ligand Binding and Dimerization, Can Be Overcome by Overexpression of Receptor* , 1997, The Journal of Biological Chemistry.
[13] T. Golde,et al. γ-Secretase Cleavage and Nuclear Localization of ErbB-4 Receptor Tyrosine Kinase , 2001, Science.
[14] D. Jans,et al. The cytokine interleukin‐5 (IL‐5) effects cotransport of its receptor subunits to the nucleus in vitro , 1997, FEBS letters.
[15] E. Lam,et al. Cell-cycle regulation of human B-myb transcription. , 1995, Gene.
[16] M. Nakao,et al. Activation of Cdh1‐dependent APC is required for G1 cell cycle arrest and DNA damage‐induced G2 checkpoint in vertebrate cells , 2001, The EMBO journal.
[17] H. Auer,et al. Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes , 2004, Cancer Research.
[18] J. Nevins,et al. E2Fs link the control of G1/S and G2/M transcription , 2004, The EMBO journal.
[19] J. Nevins,et al. Combinatorial gene control involving E2F and E Box family members , 2004, The EMBO journal.
[20] A. Gown,et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.
[21] M. Hung,et al. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. , 2005, Cancer research.
[22] M. Fiscella,et al. Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[23] B. Calabretta,et al. Requirement of B- myb Function for Survival and Differentiative Potential of Human Neuroblastoma Cells (*) , 1995, The Journal of Biological Chemistry.
[24] G. Devries,et al. Localization of neuregulin isoforms and erbB receptors in myelinating glial cells , 2004, Glia.
[25] M. Moran,et al. Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors. , 1990, Science.
[26] A. Mantovani,et al. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines. , 1992, Blood.
[27] C. Peschle,et al. B-myb Promotes S Phase and Is a Downstream Target of the Negative Regulator p107 in Human Cells (*) , 1996, The Journal of Biological Chemistry.
[28] P. Maher. Nuclear Translocation of fibroblast growth factor (FGF) receptors in response to FGF-2 , 1996, The Journal of cell biology.
[29] M. Hung,et al. Systemic tumor suppression by the proapoptotic gene bik. , 2002, Cancer research.
[30] M. Hung,et al. Differential activity of the RVF enhancer element in the decreased expression of the neu oncogene in NR‐6 cells versus parental Swiss Webster 3T3 cells , 1993, Molecular carcinogenesis.
[31] R. Watson,et al. Cell cycle regulation by the B-Myb transcription factor , 2003, Cellular and Molecular Life Sciences CMLS.
[32] K. Shigematsu,et al. Immunohistochemical expression of epidermal growth factor receptors in human adrenocortical carcinoma. , 1990, Human pathology.
[33] Sheng-Chieh Hsu,et al. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. , 2005, Cancer cell.
[34] Michael Chinkers,et al. A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. , 1982, The Journal of biological chemistry.
[35] Frank E. Jones,et al. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone , 2004, The Journal of cell biology.
[36] M. Hung,et al. Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation. , 1994, Biochemical and biophysical research communications.
[37] J. Downward,et al. Autophosphorylation sites on the epidermal growth factor receptor , 1984, Nature.
[38] J. Massagué,et al. OAZ Uses Distinct DNA- and Protein-Binding Zinc Fingers in Separate BMP-Smad and Olf Signaling Pathways , 2000, Cell.
[39] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[40] Y. Yarden. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. , 2001, European journal of cancer.
[41] J. Downward,et al. Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity. , 1985, The Journal of biological chemistry.
[42] A. Ullrich,et al. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors , 1992, Molecular and cellular biology.